Science and research

A recent study conducted in Norway suggests that tobacco snus is the most potent aid for individuals aiming to quit smoking. The research was led by Ingeborg Lund and Marianne Lund, both affiliated with the Norwegian Institute of Public Health.

Due to the rapid growth of new products, technological developments, and market changes, the European Commission is evaluating the legislative framework for tobacco control from the first quarter of 2022 to the third quarter of 2023. And shortly, the European Commission is expected to present its proposal for a new Tobacco Excise Directive.

The German Federal Institute for Risk Assessment, BfR, released a health assessment on nicotine pouches today. Among other things, it deals with harm reduction, Sweden’s low smoking rate, and the nicotine strength of nicotine pouches.

Nicotine in Swedish snus does not affect the body very much at all, according to a new study from Linköping University. The researcher likens the effect of snus on the body to coffee and says that the study provides justification for leaving snus more at peace.

A new study reveals that smokers who have suffered from heart disease could gain five healthy years by quitting.

On February 4th, the British government issued a press release announcing leads for an independent review into smoking-related health disparities. 

As the UK announces support for medical licensing of e-cigarettes, experts debate the issue in a recent published article in the British Medical Journal.

The results of a survey performed by the Ministry of Health in New Zealand show decreasing smoking rates, while the use of less harmful nicotine products increase.

On the 18th of October, 100 specialists in nicotine science, policy and practice called on the World Health Organization (WHO) to modernize its approach to tobacco policy by adopting the harm reduction perspective.

A new report by David Sundén, Doctor of Economics from Stockholm School of Economics, finds that the ban on snus (oral smokeless tobacco) in the EU has a highly negative effect on public health. The research looks at the relationship between smoking, mortality from smoking-related illnesses and snus as a risk-reducing alternative.